Quigley, H. A. Number of people with glaucoma worldwide. Br. J. Ophthalmol. 80, 389–393 (1996).
Gharahkhani, P. et al. Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries. Nat. Commun. 12, 1258 (2021).
Goodacre, R., Vaidyanathan, S., Dunn, W. B., Harrigan, G. G. & Kell, D. B. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 22, 245–252 (2004).
Roberts, L. D., Souza, A. L., Gerszten, R. E. & Clish, C. B. Targeted metabolomics. Curr. Protoc. Mol. Biol. Chapter 30 Unit 30.2.1–24 (2012).
Wang, Y., Hou, X. W., Liang, G. & Pan, C. W. Metabolomics in glaucoma: a systematic review. Investig. Ophthalmol. Vis. Sci. 62, 9 (2021).
Gong, H. et al. Gut microbiota compositional profile and serum metabolic phenotype in patients with primary open-angle glaucoma. Exp. Eye Res. 191, 107921 (2020).
Javadiyan, S. et al. Elevation of serum asymmetrical and symmetrical dimethylarginine in patients with advanced glaucoma. Investig. Ophthalmol. Vis. Sci. 53, 1923–1927 (2012).
Umeno, A. et al. Comprehensive measurements of hydroxylinoleate and hydroxyarachidonate isomers in blood samples from primary open-angle glaucoma patients and controls. Sci. Rep. 9, 1–11 (2019).
Kouassi Nzoughet, J. et al. A data mining metabolomics exploration of glaucoma. Metabolites 10, 49 (2020).
Leruez, S. et al. A metabolomics profiling of glaucoma points to mitochondrial dysfunction, senescence, and polyamines deficiency. Investig. Ophthalmol. Vis. Sci. 59, 4355–4361 (2018).
Burgess, L. G. et al. Metabolome-wide association study of primary open angle glaucoma. Investig. Ophthalmol. Vis. Sci. 56, 5020–5028 (2015).
Cabrerizo, J., Urcola, J. A. & Vecino, E. Changes in the lipidomic profile of aqueous humor in open-angle glaucoma. J. Glaucoma 26, 349–355 (2017).
Myer, C. et al. Differentiation of soluble aqueous humor metabolites in primary open-angle glaucoma and controls. Exp. Eye Res. 194, 108024 (2020).
Buisset, A. et al. Metabolomic profiling of aqueous humor in glaucoma points to taurine and spermine deficiency: Findings from the Eye-D study. J. Proteome Res. 18, 1307–1315 (2019).
Pan, C.-W. et al. Differential metabolic markers associated with primary open-angle glaucoma and cataract in human aqueous humor. BMC Ophthalmol. 20, 1–8 (2020).
Rossi, C. et al. Multi-omics approach for studying tears in treatment-naïve glaucoma patients. Int. J. Mol. Sci. 20, 4029 (2019).
Boucard, C. C., Hoogduin, J. M., van der Grond, J. & Cornelissen, F. W. Occipital proton magnetic resonance spectroscopy (1H-MRS) reveals normal metabolite concentrations in retinal visual field defects. PLoS One 2, e222 (2007).
Khanna, R. K. et al. Metabolomics and lipidomics approaches in human tears: a systematic review. Surv. Ophthalmol. 67, 1229–1243 (2022).
Breda, J. B. et al. Metabolomic profiling of aqueous humor from glaucoma patients—the metabolomics in surgical ophthalmological patients (MISO) study. Exp. Eye Res. 201, 108268 (2020).
Tang, Y. et al. Metabolomic profiling of aqueous humor and plasma in primary open-angle glaucoma patients points towards novel diagnostic and therapeutic strategy. Front. Pharmacol. 12, 621146 (2021).
Kang, J. W., Park, B. & Cho, B. J. Comparison of risk factors for initial central scotoma versus initial peripheral scotoma in normal-tension glaucoma. Korean J. Ophthalmol. 29, 102–108 (2015).
Kim, J. M., Kyung, H., Shim, S. H., Azarbod, P. & Caprioli, J. Location of Initial Visual Field Defects in Glaucoma and Their Modes of Deterioration. Investig. Ophthalmol. Vis. Sci. 56, 7956–7962 (2015).
Park, S. C. et al. Initial parafoveal versus peripheral scotomas in glaucoma: risk factors and visual field characteristics. Ophthalmology 118, 1782–1789 (2011).
Stegemann, C. et al. Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation 129, 1821–1831 (2014).
Rhee, E. P. et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J. Clin. Investig. 121, 1402–1411 (2011).
Umeno, A. et al. Comprehensive measurements of hydroxylinoleate and hydroxyarachidonate isomers in blood samples from primary open-angle glaucoma patients and controls. Sci. Rep. 9, 2171 (2019).
Rossi, C. et al. Multi-omics approach for studying tears in treatment-naive glaucoma patients. Int. J. Mol. Sci. 20, 4029 (2019).
Chen, Y. Y. et al. Patients with primary open-angle glaucoma may develop ischemic heart disease more often than those without glaucoma: an 11-year population-based cohort study. PLoS One 11, e0163210 (2016).
Newman-Casey, P. A., Talwar, N., Nan, B., Musch, D. C. & Stein, J. D. The relationship between components of metabolic syndrome and open-angle glaucoma. Ophthalmology 118, 1318–1326 (2011).
Xu, M. et al. Plasma lipid levels and risk of primary open-angle glaucoma: a genetic study using Mendelian randomization. BMC Ophthalmol. 20, 390 (2020).
Wang, S. & Bao, X. Hyperlipidemia, blood lipid level, and the risk of glaucoma: a meta-analysis. Invest Ophthalmol. Vis. Sci. 60, 1028–1043 (2019).
Pertl, L. et al. Triglycerides and open angle glaucoma—a meta-analysis with meta-regression. Sci. Rep. 7, 7829 (2017).
Rasoulinejad, S. A. et al. The association between primary open angle glaucoma and clustered components of metabolic syndrome. Open Ophthalmol. J. 9, 149–155 (2015).
Hamard, P., Hamard, H., Dufaux, J. & Quesnot, S. Optic nerve head blood flow using a laser Doppler velocimeter and haemorheology in primary open-angle glaucoma and normal pressure glaucoma. Br. J. Ophthalmol. 78, 449–453 (1994).
Shoji, M. K. et al. Paired optic nerve microvasculature and nailfold capillary measurements in primary open-angle glaucoma. Transl. Vis. Sci. Technol. 10, 13–13 (2021).
Anchisi, L., Dessi, S., Pani, A. & Mandas, A. Cholesterol homeostasis: a key to prevent or slow down neurodegeneration. Front. Physiol. 3, 486 (2012).
Huynh, K. et al. Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease. Nat. Commun. 11, 5698 (2020).
Llano, D. A. & Devanarayan, V., Alzheimer’s Disease Neuroimaging, I. Serum phosphatidylethanolamine and lysophosphatidylethanolamine levels differentiate Alzheimer’s disease from controls and predict progression from mild cognitive impairment. J. Alzheimer’s Dis. 80, 311–319 (2021).
Wood, P. L. et al. Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late-onset Alzheimer’s disease (LOAD). BBA Clin. 5, 25–28 (2016).
Meikle, P. J. et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One 8, e74341 (2013).
Mejia, E. M. & Hatch, G. M. Mitochondrial phospholipids: role in mitochondrial function. J. Bioenerg. Biomembr. 48, 99–112 (2016).
Liu, P. et al. The mechanisms of lysophosphatidylcholine in the development of diseases. Life Sci. 247, 117443 (2020).
Leruez, S. et al. A plasma metabolomic signature of the exfoliation syndrome involves amino acids, acylcarnitines, and polyamines. Investig. Ophthalmol. Vis. Sci. 59, 1025–1032 (2018).
Ho, L. T. Y. et al. Role of the autotaxin-lysophosphatidic acid axis in glaucoma, aqueous humor drainage and fibrogenic activity. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165560 (2020).
Honjo, M. et al. Autotaxin-lysophosphatidic acid pathway in intraocular pressure regulation and glaucoma subtypes. Investig. Ophthalmol. Vis. Sci. 59, 693–701 (2018).
Milbeck, S. M. & Bhattacharya, S. K. Alteration in lysophospholipids and converting enzymes in glaucomatous optic nerves. Investig. Ophthalmol. Vis. Sci. 61, 60 (2020).
Edwards, G., Aribindi, K., Guerra, Y., Lee, R. K. & Bhattacharya, S. K. Phospholipid profiles of control and glaucomatous human aqueous humor. Biochimie 101, 232–247 (2014).
Aribindi, K., Guerra, Y., Lee, R. K. & Bhattacharya, S. K. Comparative phospholipid profiles of control and glaucomatous human trabecular meshwork. Investig. Ophthalmol. Vis. Sci. 54, 3037–3044 (2013).
Aljohani, A. J. et al. Human trabecular meshwork sphingolipid and ceramide profiles and potential latent fungal commensalism. Investig. Ophthalmol. Vis. Sci. 55, 3413–3422 (2014).
Aljohani, A. J., Munguba, G. C., Guerra, Y., Lee, R. K. & Bhattacharya, S. K. Sphingolipids and ceramides in human aqueous humor. Mol. Vis. 19, 1966 (2013).
Chauhan, M. Z., Valencia, A.-K., Piqueras, M. C., Enriquez-Algeciras, M. & Bhattacharya, S. K. Optic nerve lipidomics reveal impaired glucosylsphingosine lipids pathway in glaucoma. Investig. Ophthalmol. Vis. Sci. 60, 1789–1798 (2019).
Kamel, K., Farrell, M. & O’Brien, C. Mitochondrial dysfunction in ocular disease: focus on glaucoma. Mitochondrion 35, 44–53 (2017).
Liu, H., Mercieca, K. & Prokosch, V. Mitochondrial markers in aging and primary open-angle glaucoma. J. Glaucoma 29, 295–303 (2020).
Kong, G. Y., Van Bergen, N. J., Trounce, I. A. & Crowston, J. G. Mitochondrial dysfunction and glaucoma. J. Glaucoma 18, 93–100 (2009).
Chrysostomou, V., Rezania, F., Trounce, I. A. & Crowston, J. G. Oxidative stress and mitochondrial dysfunction in glaucoma. Curr. Opin. Pharm. 13, 12–15 (2013).
Izzotti, A., Bagnis, A. & Sacca, S. C. The role of oxidative stress in glaucoma. Mutat. Res. 612, 105–114 (2006).
Benoist d’Azy, C., Pereira, B., Chiambaretta, F. & Dutheil, F. Oxidative and anti-oxidative stress markers in chronic glaucoma: a systematic review and meta-analysis. PLoS One 11, e0166915 (2016).
Williams, P. A. et al. Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science 355, 756–760 (2017).
Gonzalez-Granda, A., Damms-Machado, A., Basrai, M. & Bischoff, S. C. Changes in plasma acylcarnitine and lysophosphatidylcholine levels following a high-fructose diet: a targeted metabolomics study in healthy women. Nutrients 10, 1254 (2018).
Calandrella, N., De Seta, C., Scarsella, G. & Risuleo, G. Carnitine reduces the lipoperoxidative damage of the membrane and apoptosis after induction of cell stress in experimental glaucoma. Cell Death Dis. 1, e62 (2010).
Zarnowski, T. et al. A ketogenic diet may offer neuroprotection in glaucoma and mitochondrial diseases of the optic nerve. Med Hypothesis Discov. Innov. Ophthalmol. 1, 45–49 (2012).
Bailey, J. N. et al. Hypothesis-independent pathway analysis implicates GABA and acetyl-CoA metabolism in primary open-angle glaucoma and normal-pressure glaucoma. Hum. Genet. 133, 1319–1330 (2014).
Hanyuda, A. et al. Low-carbohydrate-diet scores and the risk of primary open-angle glaucoma: data from three US cohorts. Eye 34, 1465–1475 (2020).
Khawaja, A. P. et al. Assessing the association of mitochondrial genetic variation with primary open-angle glaucoma using gene-set analyses. Investig. Ophthalmol. Vis. Sci. 57, 5046–5052 (2016).
Zeleznik, O. A. et al. Circulating amino acids and amino acid-related metabolites and risk of breast cancer among predominantly premenopausal women. NPJ Breast cancer 7, 1–10 (2021).
Zeleznik, O. A. et al. Circulating lysophosphatidylcholines, phosphatidylcholines, ceramides, and sphingomyelins and ovarian cancer risk: a 23-year prospective study. J. Natl Cancer Inst. 112, 628–636 (2020).
Zeleznik, O. A. et al. A prospective analysis of circulating plasma metabolites associated with ovarian cancer risk. Cancer Res. 80, 1357–1367 (2020).
Townsend, M. K. et al. Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. Clin. Chem. 59, 1657–1667 (2013).
Zeleznik, O. A. et al. Intrapersonal stability of plasma metabolomic profiles over 10 years among women. Metabolites 12, 372 (2022).
Kang, J. H., Loomis, S. J., Rosner, B. A., Wiggs, J. L. & Pasquale, L. R. Comparison of risk factor profiles for primary open-angle glaucoma subtypes defined by pattern of visual field loss: a prospective study. Investig. Ophthalmol. Vis. Sci. 56, 2439–2448 (2015).
Kang, J. H., Willett, W. C., Rosner, B. A., Hankinson, S. E. & Pasquale, L. R. Prospective study of alcohol consumption and the risk of primary open-angle glaucoma. Ophthalmic Epidemiol. 14, 141–147 (2007).
Bailey, J. N. et al. Genome-wide association analysis identifies TXNRD2, ATXN2 and FOXC1 as susceptibility loci for primary open-angle glaucoma. Nat. Genet. 48, 189–194 (2016).
Hysi, P. G. et al. Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma. Nat. Genet. 46, 1126–1130 (2014).
Wiggs, J. L. et al. The NEIGHBOR consortium primary open-angle glaucoma genome-wide association study: rationale, study design, and clinical variables. J. Glaucoma 22, 517–525 (2013).
Wiggs, J. L. et al. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma in Caucasians from the USA. Hum. Mol. Genet. 20, 4707–4713 (2011).
MacGregor, S. et al. Genome-wide association study of intraocular pressure uncovers new pathways to glaucoma. Nat. Genet. 50, 1067–1071 (2018).
Khawaja, A. P. et al. Genome-wide analyses identify 68 new loci associated with intraocular pressure and improve risk prediction for primary open-angle glaucoma. Nat. Genet. 50, 778–782 (2018).
Kim, J. et al. Intraocular pressure, glaucoma, and dietary caffeine consumption: a gene-diet interaction study from the UK Biobank. Ophthalmology 128, 866–876 (2021).
Kim, J. et al. Statin use in relation to intraocular pressure, glaucoma, and ocular coherence tomography parameters in the UK Biobank. Investig. Ophthalmol. Vis. Sci. 63, 31 (2022).
Han, X. et al. Associations of sleep apnoea with glaucoma and age-related macular degeneration: an analysis in the United Kingdom Biobank and the Canadian longitudinal study on aging. BMC Med 19, 104 (2021).
Paynter, N.P. et al. Metabolic predictors of incident coronary heart disease in women. Circulation 137, 841–853 (2018)
O’Sullivan, J. F. et al. Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes. J. Clin. Invest 127, 4394–4402 (2017).
Mascanfroni, I. D. et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha. Nat. Med. 21, 638–646 (2015).
Julkunen, H., Cichonska, A., Slagboom, P. E. & Wurtz, P., Nightingale Health, U.K.B.I. Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population. Elife 10, e63033 (2021).
Soininen, P., Kangas, A. J., Wurtz, P., Suna, T. & Ala-Korpela, M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ. Cardiovasc. Genet. 8, 192–206 (2015).
Mihaleva, V. V. et al. Automated quantum mechanical total line shape fitting model for quantitative NMR-based profiling of human serum metabolites. Anal. Bioanal. Chem. 406, 3091–3102 (2014).
Kang, J. H. et al. Association of dietary nitrate intake with primary open-angle glaucoma: a prospective analysis from the nurses’ health study and health professionals follow-up study. JAMA Ophthalmol. 134, 294–303 (2016).
Kang, J. H., Willett, W. C., Rosner, B. A., Hankinson, S. E. & Pasquale, L. R. Caffeine consumption and the risk of primary open-angle glaucoma: a prospective cohort study. Investig. Ophthalmol. Vis. Sci. 49, 1924–1931 (2008).
Chiuve, S. E. et al. Alternative dietary indices both strongly predict risk of chronic disease. J. Nutr. 142, 1009–1018 (2012).
Gao, X., Starmer, J. & Martin, E. R. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol. 32, 361–369 (2008).
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. 102, 15545–15550 (2005).
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289–300 (1995).